Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trial simulation: a tool for understanding study failures and preventing them.

Pascal Girard1

  • 1EA 3738, INSERM, Faculty of Medicine Lyon South, BP12, 69921 Oullins Cedex, France. pascal.girard@adm.univ-lyon1.fr

Basic & Clinical Pharmacology & Toxicology
|March 1, 2005
PubMed
Summary

Execution models help predict how protocol deviations impact clinical trial power. These models identify study design weaknesses before trials begin, improving robustness and ensuring reliable results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency Coding of Multisensory Integration in the Local Field Potentials of the Medial Pulvinar.

The European journal of neuroscience·2025
Same author

Historical Use of Markov Model and Posterior Predictive Checks in Pharmacometrics.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Generative models for synthetic data generation: application to pharmacokinetic/pharmacodynamic data.

Journal of pharmacokinetics and pharmacodynamics·2024
Same author

Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer.

Clinical pharmacology and therapeutics·2024
Same author

Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non-small cell lung cancer based on bintrafusp alfa trials.

CPT: pharmacometrics & systems pharmacology·2023
Same author

Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials.

CPT: pharmacometrics & systems pharmacology·2023

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Clinical trials rely on adherence to study protocols for accurate efficacy and safety assessments.
  • Protocol deviations can decrease statistical power and lead to study failure.
  • Quantifying the impact of deviations, especially combined ones, is challenging.

Purpose of the Study:

  • To introduce execution models as a method for analyzing protocol deviations in clinical trials.
  • To demonstrate the utility of execution models in identifying potential study design weaknesses.
  • To highlight the role of execution models in enhancing clinical trial robustness.

Main Methods:

  • Utilizing longitudinal stochastic models to simulate individual participant behavior.

Related Experiment Videos

  • Employing modeling and simulation techniques to assess the consequences of protocol deviations.
  • Analyzing the impact of deviations on statistical power and residual variability.

    • Main Results:

    • Execution models can quantitatively estimate the effects of protocol deviations on study outcomes.
    • These models reveal weaknesses in proposed study designs that might otherwise be overlooked.
    • Simulation results inform strategies to mitigate risks associated with protocol deviations.

    Conclusions:

    • Execution models are essential tools for clinical trial simulation and design.
    • They enable proactive identification and resolution of potential issues, increasing study robustness.
    • Incorporating execution models improves the reliability of clinical trial results.